Dimethyl sulfoxide (DMSO) is widely used as a solvent in endovascular embolization procedures, yet its potential neurotoxic effects remain underexplored. In this correspondence, we highlight emerging evidence suggesting that DMSO exposure may contribute to the development of hydrocephalus through mechanisms involving ependymal damage and astrocyte apoptosis. Drawing on recent experimental findings, we propose that DMSO-induced neuroinflammation may play a role in post-embolization complications. We urge the research community to consider hydrocephalus as a possible, though unproven, outcome of DMSO exposure and to include it in long-term safety assessments of embolic agents.
VerheijenMLienhardMSchroodersY, et al.DMSO induces drastic changes in human cellular processes and epigenetic landscape in vitro. Sci Rep2019; 9: 4641.
2.
ElisiaINakamuraHLamV, et al.DMSO Represses inflammatory cytokine production from human blood cells and reduces autoimmune arthritis. PLoS one2016; 11: e0152538.
3.
WongCHDeyPYarmushJ, et al.Nifedipine-induced analgesia after epidural injection in rats. Anesth Analg1994; 79: 303–305.
4.
LvYWuJZhangJ, et al.Rheological properties of cellulose/ionic liquid/dimethylsulfoxide (DMSO) solutions. Polymer2012; 53: 2524–2531.
5.
KoGChoiJWLeeN, et al.Recent progress in liquid embolic agents. Biomaterials2022; 287: 121634.
6.
TakiWYonekawaYIwataH, et al.A new liquid material for embolization of arteriovenous malformations. American Journal of Neuroradiology1990; 11: 163–168.
7.
VollherbstDFChapotRBendszusM, et al.Glue, onyx, squid or PHIL? Liquid embolic agents for the embolization of cerebral arteriovenous malformations and dural arteriovenous fistulas. Clin Neuroradiol2022; 32: 25–38.
8.
PollakJSWhite JrRI. The use of cyanoacrylate adhesives in peripheral embolization. J Vasc Interv Radiol2001; 12: 907–913.
9.
MurayamaYViñuelaFUlhoaA, et al.Nonadhesive liquid embolic agent for cerebral arteriovenous malformations: preliminary histopathological studies in swine rete mirabile. Neurosurgery1998; 43: 1164–1172.
10.
ChenRZhangSYouC, et al.Pediatric intracranial aneurysms: changes from previous studies. Child's Nerv Syst2018; 34: 1697–1704.
11.
LvXJiangCLiY, et al.Clinical outcomes of endovascular treatment for intracranial pial arteriovenous fistulas. World Neurosurg2010; 73: 385–390.
12.
RekateHL. A contemporary definition and classification of hydrocephalus. Semin Pediatr Neurol. Mar2009; 16: 9–15.
13.
RobertSMReevesBCKiziltugE, et al.The choroid plexus links innate immunity to CSF dysregulation in hydrocephalus. Cell2023; 186: 764–785 21.
14.
Garcia-BonillaMCastaneyra-RuizLZwickS, et al.Acquired hydrocephalus is associated with neuroinflammation, progenitor loss, and cellular changes in the subventricular zone and periventricular white matter. Fluids Barriers CNS2022; 19: 17.
15.
Castaneyra-RuizLMcAllister 2ndJPMoralesDM, et al.Preterm intraventricular hemorrhage in vitro: modeling the cytopathology of the ventricular zone. Fluids Barriers CNS2020; 17: 46.
16.
Castaneyra-RuizLGonzalez-MarreroIHernandez-AbadLG, et al.AQP4 labels a subpopulation of white matter-dependent glial radial cells affected by pediatric hydrocephalus, and its expression increased in glial microvesicles released to the cerebrospinal fluid in obstructive hydrocephalus. Acta Neuropathol Commun2022; 10: 41.
17.
Castaneyra-RuizLLedbetterJLeeS, et al.Intraventricular dimethyl sulfoxide (DMSO) induces hydrocephalus in a dose-dependent pattern. Heliyon2024; 10: e27295.
18.
BroadwellRDSalcmanMKaplanRS. Morphologic effect of dimethyl sulfoxide on the blood-brain barrier. Science1982; 217: 164–166.
